ClinicalTrials.gov
ClinicalTrials.gov Menu

A Trial Evaluating the Efficacy and Safety of Tenecteplase Together With Unfractionated Heparin Prior to Early Percutaneous Coronary Intervention (PCI) as Compared to Standard Primary PCI in Patients With Acute Myocardial Infarction (ASSENT 4 PCI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00168792
Recruitment Status : Terminated
First Posted : September 15, 2005
Last Update Posted : October 29, 2013
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by:
Boehringer Ingelheim

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : July 2006
  Study Completion Date : No date given
Publications of Results:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):